Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
Miguel Brito, Research Coordinator at H&TRC – Health and Technology Research center, shared post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Highlights
Newborn screening of 13,000+ infants in Luanda, Angola, identified a sickle cell disease prevalence of 1.38%.
Sickle cell trait was common, affecting 20.31% of screened newborns.
Follow-up of diagnosed patients is challenging due to low disease literacy and socioeconomic barriers.
With: Catarina Ginete , Baba Inusa, Jocelyne Neto de Vasconcelos NBS and paper with the support of Arise Initiative.
And the support of Revvity for Diagnostics and H&TRC – Health and Technology Research Center”
Title: Newborn screening for sickle cell disease in Angola: Implementation challenges and emerging data on hemoglobinopathy prevalence
Authors: Miguel Brito, Catarina Ginete, Mariana Jacinto, Manuela Mendes, Hailton Soares, Roberto Afonso, Adriano Siatembo, Jocelyne Vasconcelos, Baba Inusa
Read the Full Article on Blood Cells, Molecules and Diseases

Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies